CRYOPORT, INC. Prepaid Expense and Other Assets, Current
CRYOPORT, INC. (CYRX) had Prepaid Expense and Other Assets, Current of $5.55 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $5.55M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $6.15M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $8.42M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $5.29M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.55M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $6.15M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $8.42M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $5.29M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $7.07M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $7.44M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.94M 10-K · filed 2026-03-05 | $11.57M 10-K · filed 2025-03-07 |
| 2024-09-30 | $10.66M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $11.07M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $10.89M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $10.08M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $11.55M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $8.62M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $9.96M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $9.32M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $10.64M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $8.25M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $8.36M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $8.80M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $8.96M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $12.57M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $18.48M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $11.93M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.44M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $891.65K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.10M 10-K · filed 2021-03-01 | $1.10M 10-K · filed 2020-03-10 |
| 2019-09-30 | $872.44K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $526.65K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $741.61K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $752.27K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $882.14K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $502.62K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $541.46K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $516.43K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $264.34K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $308.93K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $321.42K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $286.92K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $606.82K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $288.95K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $248.73K 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $97.34K 10-K · filed 2016-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |